Clinical trials
Phase 2 Uveitis, Intermediate trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Terminated | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Eye Institute (NEI) | 2 |
| ACELYRIN Inc. | 1 |
| Alumis Inc | 1 |
| Clearside Biomedical, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| Quan Dong Nguyen | 1 |
| Stanford University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uveitis, Intermediate | 8 |
| Uveitis | 7 |
| Uveitis, Posterior | 5 |
| Panuveitis | 4 |
| Behcet Syndrome | 1 |
| Birdshot Chorioretinopathy | 1 |
| Choroidal Effusions | 1 |
| Inflammation | 1 |
| Macular Edema | 1 |
| Multifocal Choroiditis | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.